NCT01141764

Brief Summary

The purpose of this research study is to evaluate the brain circuits function and circuits involved in the mechanism of thalamic DBS in patients with medically refractory epilepsy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Mar 2010

Typical duration for phase_3

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 10, 2010

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

November 21, 2014

Status Verified

November 1, 2014

Enrollment Period

3.9 years

First QC Date

June 7, 2010

Last Update Submit

November 20, 2014

Conditions

Keywords

pediatricsEpilepsyDeep Brain StimulationPositron Emission Tomography

Outcome Measures

Primary Outcomes (1)

  • Areas of the brain with low activity

    This measure will be based on the results of two PET scans done on separate days. The stimulator will be "on" during the first PET image acquisition and "off" during the second PET image acquisition.

    within 30 days of enrollment in the study

Secondary Outcomes (2)

  • Brain Abnormalities

    within 30 days of enrollment in the study

  • Ability to learn and understand

    within 30 days of enrollment in the study

Study Arms (1)

Study Group

EXPERIMENTAL

In our study, patients will be scanned with their DBS electrodes turned "on" and "off". Participation involves undergoing 2 separate PET scans on 2 separate days. The MRI and neuropsychological tests will either be performed on the same day as one of the PET scans or on a separate day. Procedures performed in this study are not part of the standard management of epilepsy.

Procedure: Positron Emission Tomography (PET) ScanProcedure: Magnetic Resonance Imaging (MRI)Other: Neuropsychological Testing

Interventions

The PET procedure consists of an intravenous injection of 18F-FDG followed by a 45-minute period of quiet resting. PET images will be acquired on an integrated PET/CT scanner. This process will be repeated with the stimulator "on" during the first PET image acquisition and "off" during the second PET image acquisition. "On" and "off" PET image acquisitions will be performed on two separate days.

Study Group

MRI will be performed on a 1.5T system, using a combination of different sequences including sagittal T1, coronal and axial T2, FLAIR and proton density and axial 3D T1 weighted images.

Study Group

On the same day or separate visit, depending on the timing of the PET imaging, they will be required to attend one half-day session for neuropsychological testing. Patients will arrive at the Toronto Western Hospital, the stimulator will be turned "off" for 30 minutes prior to neuropsychological testing with testing repeated with the stimulator on.

Study Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • currently have DBS implanted for medically refractory epilepsy
  • Women of childbearing age will be required to use established contraceptive methods while enrolled in the study.

You may not qualify if:

  • Patients who:
  • are \< 18 years of age or \> 85 years of age
  • are medically unstable
  • are women who are potentially pregnant, pregnant or nursing
  • have had PET imaging within 1 year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Location

MeSH Terms

Conditions

Epilepsy

Interventions

Magnetic Resonance Spectroscopy2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazoleNeuropsychological Tests

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesPsychological TestsBehavioral Disciplines and Activities

Study Officials

  • Elysa Widjaja, MD

    The Hospital for Sick Children, Toronto Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Neuroradiologist

Study Record Dates

First Submitted

June 7, 2010

First Posted

June 10, 2010

Study Start

March 1, 2010

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

November 21, 2014

Record last verified: 2014-11

Locations